Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**EuBone** is a proprietary multi-herb botanical blend formulated from *Eucommia ulmoides*, *Drynaria fortunei*, and *Cuscuta chinensis*. It is being evaluated as an oral capsule for preservation of bone health in postmenopausal women, including slowing bone loss and preventing or improving osteopenia. Its proposed activity is modulation of bone remodeling and calcium-phosphorus homeostasis, but a definitive molecular target and clinically established mechanism have not been identified. EuBone is marketed and developed as a nutraceutical botanical ingredient rather than as an approved pharmaceutical medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on EuBone (Chenland Nutritionals).